In recent years, progress has been made in the areas of preventing leprosy through drugs (chemoprophylaxis) and through vaccination (immunoprophylaxis). Several organisations and institutions are researching many aspects, including the combined effect of chemoprophylaxis and immunoprophylaxis, testing potential chemoprophylactic regimens, testing the feasibility and effectiveness of a single-dose antibiotic, and looking at aspects of the immune system in relation to prophylaxis.
Surveillance of resistance to anti-leprosy drugs – Eisai, World Health Organization (WHO), Laboratoire de Microbiologie (LRB)
Development and application of serological tests that impact on the transmission and prevention of sequelae of leprosy in an endemic population of Colombia – Instituto Colombiano de Medicina Tropical
Basic research at Stanley Browne Laboratory, New Delhi, India – The Leprosy Mission Trust India (TLMTI)
ILEP Member projects
Some Members are involved in research projects related to immunoprophylaxis and chemoprophylaxis. Members are also involved in the supply of medicines and medical supplies, for example providing a single dose chemoprophylaxis (rifampicin) to close contacts of people diagnosed with leprosy.
Download more details